Recombinant human FGFBP1 cDNA (24 – 234 aa, derived from BC008910) fused with T7-His-TEV cleavage site Tag (29aa) at N-terminal was expressed in E. coli.
0.5 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, arginine, DTT and Glycerol.
MASMTGGQQMGRGHHHHHHENLYFQGGEFKKKVKNGLHSKVVSEQKDTLGNTQIKQKSRPGNKGKFVTKDQANCR WAATEQEEGISLKVECTQLDHEFSCVFAGNPTSCLKLKDERVYWKQVARNLRSQKDICRYSKTAVKTRVCRKDFP ESSLKLVSSTLFGNTKPRKEKTEMSPREHIKGKETTPSSLAVTQTMATKAPECVEDPDMANQRKTALEFCGETWS SLCTFFLSIVQDTSC
1. May be used for in vitro FGFBP1 protein mediated tumor endothelial cell differentiation regulation study with this protein as either coating matrix protein or as soluble factor.2. May be used for FGFBP1 protein – protein interaction assay.3. May be used as enzymatic substrate for various proteases.4. May be used for specific antibody production.
Keep at -80centigrade for long term storage. Product is stable at 4 centigrade for at least 30 days.